E-mailing Doctors Desirable for Those with Comorbidities

Patients who have multiple comorbidities and who take multiple medications may benefit most from a secure e-mail messaging system, according to a study conducted by the Kaiser Family Foundation that appeared in the American Journal of Managed Care. Members of Kaiser Permanente's northwest region were given access to parts of their individual health records through a secure member Web site. Electronic messaging capability was provided within this secure Web environment.

Members who used this online Web site exhibited a decrease in primary care outpatient visits of 6.7 percent. Members who used the messaging feature had a smaller increase in telephone calls to their physician (16.2 percent versus 29.9 percent) compared to the control group, which did not have access to secure messaging.

"There are much more efficient ways to provide better care using electronic medical records, especially when the impact of secure messaging is considered," says Louise L. Liang, MD, one of the authors of the study.

She is senior vice president for quality and clinical systems support at Kaiser Foundation Health Plan.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.